StockData
Vogenx, Inc. logo

Vogenx, Inc. (VOGX) stock

VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$12.34−1.14 (-8.46%)

Close on Nov 18, 2026Market cap $183.31MP/E –Yield –

Vogenx r&d expenses

Research and development expenses are spending on new products and technology.

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$156.79K–
Q2 FY2025Jun 30, 2025$136.39K–

More Vogenx figures

See a number that looks wrong?